US 9,221,788 · Application 13/962,745 · Granted Dec 29, 2015
US 9,221,788
Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
Estimated expiration
September 25, 2033
6y 338d remaining
Earliest effective filing
Aug 8, 2013
+ 20 years
Aug 8, 2033
PTA +48d
Sep 25, 2033
No TD
—
Final
Sep 25, 2033
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- August 8, 2013
- Earliest effective filing
- August 8, 2013
- Issue date
- December 29, 2015
- PTA
- +48 days
- Base expiry (before PTA)
- August 8, 2033
August 8, 2013 + 20 years = August 8, 2033 + 48 PTA days = September 25, 2033
- PRO61/681,484 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/962,745 · US 9,221,788
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,221,788: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9221788Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.